4.4 Article

Effects of preoperative serum lactate dehydrogenase levels on long-term prognosis in elderly patients with hepatocellular carcinoma undergoing transcatheter arterial chemoembolization

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Oncology

Is it possible to halve the incidence of liver cancer in China by 2050?

Ju-Fang Shi et al.

Summary: A substantial proportion of liver cancers are caused by chronic infections of hepatitis B and C. The global mortality rate for liver cancer remains high, with varying trends in different countries. China has historically had a significant burden of liver cancer, but recent data show a decline in liver cancer incidence in the country.

INTERNATIONAL JOURNAL OF CANCER (2021)

Article Gastroenterology & Hepatology

Cancer-Associated Fibroblasts Provide a Stromal Niche for Liver Cancer Organoids That Confers Trophic Effects and Therapy Resistance

Jiaye Liu et al.

Summary: The study successfully established murine and human 3D co-culture models and demonstrated robust effects of cancer-associated fibroblasts (CAFs) in nurturing liver cancer and promoting treatment resistance.

CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY (2021)

Article Biochemistry & Molecular Biology

Lactate dehydrogenase and malate dehydrogenase: Potential antiparasitic targets for drug development studies

Francis Kayamba et al.

Summary: This review highlights the importance of parasitic lactate dehydrogenases (LDH) and malate dehydrogenases (MDH) as potential therapeutic targets for the development of novel antiparasitic agents. These enzymes play a critical role in the progression and development of parasitic diseases, making them essential for the future development of effective treatments.

BIOORGANIC & MEDICINAL CHEMISTRY (2021)

Article Gastroenterology & Hepatology

Acetylation of lactate dehydrogenase B drives NAFLD progression by impairing lactate clearance

Tongxin Wang et al.

Summary: The study found that hyperacetylation of LDHB in NAFL and NASH livers leads to lactate accumulation, exacerbating lipid deposition and inflammatory responses. Inhibition of PCAF and the generation of an acetylation-deficient mutant of LDHB can ameliorate NASH, suggesting a potential therapeutic target for the disease.

JOURNAL OF HEPATOLOGY (2021)

Article Medicine, Research & Experimental

Lactate dehydrogenase B regulates macrophage metabolism in the tumor microenvironment

Ann-Christin Frank et al.

Summary: The study revealed that tumor-derived miR-375 regulates glucose metabolism in TAMs by targeting LDHB, promoting breast cancer progression. Downregulation of LDHB in TAMs shifts their function to serve as an energy source for tumor cells, accelerating tumor proliferation. Therefore, the miR-375-LDHB axis could be a potential target for interventions in tumor growth.

THERANOSTICS (2021)

Review Oncology

The immunological and metabolic landscape in primary and metastatic liver cancer

Xin Li et al.

Summary: This review discusses the unique immunological and metabolic features of the liver during cancer development, and how these factors can impact the development of primary liver cancer and liver metastases. The liver is often influenced by chronic inflammation and metabolic alterations, which may affect cancer metastasis.

NATURE REVIEWS CANCER (2021)

Review Immunology

Lactate modulation of immune responses in inflammatory versus tumour microenvironments

Michelangelo Certo et al.

Summary: The microenvironments of cancerous tissues and tissues affected by chronic inflammatory diseases exhibit different immune states but similar metabolic states. Understanding the metabolic signature allows for therapeutic intervention to reset metabolite availability and correct dysregulated immune states.

NATURE REVIEWS IMMUNOLOGY (2021)

Review Dermatology

Lactate dehydrogenase in dermatology practice

A. Livesey et al.

CLINICAL AND EXPERIMENTAL DERMATOLOGY (2020)

Review Biochemistry & Molecular Biology

Challenges in liver cancer and possible treatment approaches

David Anwanwan et al.

BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2020)

Article Emergency Medicine

Lactate dehydrogenase levels predict coronavirus disease 2019 (COVID-19) severity and mortality: A pooled analysis

Brandon Michael Henry et al.

AMERICAN JOURNAL OF EMERGENCY MEDICINE (2020)

Review Nutrition & Dietetics

Diet and liver cancer risk: a narrative review of epidemiological evidence

Wan-Shui Yang et al.

BRITISH JOURNAL OF NUTRITION (2020)

Review Biochemistry & Molecular Biology

Radiolabeled Peptide Probes for Liver Cancer Imaging

Rui Cao et al.

CURRENT MEDICINAL CHEMISTRY (2020)

Review Endocrinology & Metabolism

The Biochemical and Clinical Perspectives of Lactate Dehydrogenase: An Enzyme of Active Metabolism

Amjad A. Khan et al.

ENDOCRINE METABOLIC & IMMUNE DISORDERS-DRUG TARGETS (2020)

Review Oncology

Lactate dehydrogenase: a marker of diminished antitumor immunity

Sandra Van Wilpe et al.

ONCOIMMUNOLOGY (2020)

Review Biochemistry & Molecular Biology

New insights on sorafenib resistance in liver cancer with correlation of individualized therapy

Zhang Cheng et al.

BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2020)

Review Biochemistry & Molecular Biology

The usefulness of lactate dehydrogenase measurements in current oncological practice

Agata Forkasiewicz et al.

CELLULAR & MOLECULAR BIOLOGY LETTERS (2020)

Review Medicine, Research & Experimental

Hypoxia-inducible factors and innate immunity in liver cancer

Vincent Wai-Hin Yuen et al.

JOURNAL OF CLINICAL INVESTIGATION (2020)

Article Oncology

Lysine-222 succinylation reduces lysosomal degradation of lactate dehydrogenase a and is increased in gastric cancer

Xiang Li et al.

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2020)

Review Biochemistry & Molecular Biology

Aldehyde Dehydrogenase, Liver Disease and Cancer

Wenjun Wang et al.

INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2020)